Abstract
The effect of the non-N-methyl-D-aspartate (NMDA) agonists (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and quisqualate (QUIS) on the release of acetylcholine (ACh), gamma-amino butyric acid (GABA), aspartate (Asp) and glutamate (Glu) from the hippocampus of freely moving rats was studied by transversal microdialysis. Intracerebroventricular (i.c.v.) administration of the non-NMDA receptor agonist AMPA (0.5 nmol) enhanced (by about 200%) ACh release from the hippocampus. The effect of AMPA was completely antagonized by 6-nitro-7-sulphamoyl-benz(f)quinoxaline-2,3-dione (NBQX; 2 nmol, i.c.v). No effect was seen when AMPA was perfused through the septum. However, AMPA (200 microM) locally applied to the hippocampus, increased (by about 200%) ACh release. QUIS (200 microM) applied locally to the hippocampus produced a long-lasting increase in the release of ACh (by about 215%) and GABA (by about 460%). Local infusion of tetrodotoxin (1 microM) decreased ACh and GABA basal extracellular levels, and abolished the QUIS-induced increase in ACh and GABA. Our results demonstrate that non-NMDA glutamatergic receptors in the hippocampus regulate hippocampal release of GABA and ACh.
References
Sep 24, 1986·Brain Research·D R Stevens, C W Cotman
Jun 15, 1986·The Journal of Comparative Neurology·B OntenienteT Maeda
Jun 1, 1971·Journal of Neurochemistry·J Storm-Mathisen, F Fonnum
Jan 1, 1984·Experimental Brain Research·M Joëls, I J Urban
Oct 24, 1980·Journal of Chromatography·K Lenda, G Svenneby
Jan 1, 1995·Neuron·A V PaternainJ Lerma
Nov 1, 1994·Pharmacology, Biochemistry, and Behavior·A MarighettoR Jaffard
Jun 1, 1994·Neurochemistry International·R JanákyP Saransaari
Jan 1, 1993·Journal of Neurochemistry·Y BesshoS Nakanishi
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·U StaubliG Lynch
Jan 1, 1997·Annual Review of Psychology·B J Everitt, T W Robbins
Citations
May 12, 2004·Neuroscience Letters·Susanna RosiGiancarlo Pepeu
Aug 5, 2000·European Journal of Pharmacology·C LebrunP Lestage
Aug 5, 2000·European Journal of Pharmacology·B LockhartP Lestage
Oct 8, 1999·European Journal of Pharmacology·K Nakamura, M Shirane
Apr 27, 2000·Neurochemistry International·L G HarsingS Sólyom
Feb 1, 2002·Neurochemistry International·Angelina RakovskaElena Djambazova
May 14, 2003·Neurochemistry International·Pirjo Saransaari, Simo S Oja
Jan 1, 1997·Epilepsy Research·C E StafstromG L Holmes
Mar 15, 2006·CNS Drugs·Stefano Marenco, Daniel R Weinberger
Mar 4, 2000·Neuropharmacology·M Shirane, K Nakamura
Jan 1, 2013·In Silico Pharmacology·Sarah FliegelHamid R Noori
Oct 4, 2005·Neuroscience·M G GiovanniniG Pepeu
Jun 16, 2004·Neuroscience Letters·Cornelia KiewertJochen Klein
Jul 1, 2004·Hippocampus·Tibor HajszanCsaba Leranth
Dec 20, 2005·Neurochemical Research·Pirjo Saransaari, Simo S Oja
Aug 29, 2019·Cellular and Molecular Neurobiology·Bihter AvsarWalter J Lukiw
Oct 18, 2007·Neurochemical Research·Pirjo Saransaari, Simo S Oja